secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2025-02-28T23:59:59+00:00
Accession:  0001664710-25-000022
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros CEO to present at TD Cowen and Leerink healthcare conferences in March
----------------------------------------------------------------------------

- CEO Jasbir Seehra to present at TD Cowen 45th Annual Healthcare Conference on March 3, 2025 at 9:50 a.m. ET.
- CEO to present at Leerink Partners Global Healthcare Conference on March 10, 2025 at 1:40 p.m. ET.
- Both presentations will be in fireside chat format with webcast links provided.
- Archived replays available on Keros investor website for up to 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000022/0001664710-25-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000022/kros-20250228.htm
  HTML page:      https://secwatch.observer/filing/0001664710-25-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer